Effect of dialysis dose and membrane flux in maintenance hemodialysis.

By F. Locatelli. New England Journal of Medicine, 2003

914 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Survival advantages of obesity in dialysis patients. (2005, background): “ing the HEMO (3) and ADAMEX (4) studies, failed to show any”
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. (2007, unknown): “Median (interquartile range), y 3 (1-9) 4 (2-6)”
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. (2015, methodology): “(B) When normalized to BSA, women randomized in men.(129) Reproduced with permission of the American Society”
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? (2008, background): “trolled trials have consistently shown no survival benefit from multiple new treatment strategies, such as increased dialysis dose (2,3), intensified nutrition (4), homocysteine-lowering therapy (5), normalization of hemoglobin with erythropoietin (6,7), lipid lowering with statins (8), and treatmen”